Spine Pain Management to Generate nearly US$ 12.5 Billion in Revenue by 2033 | FMI

 According to Future Market Insights’ recent report, the Spine Pain Market is forecast to register a CAGR of 5% from 2023-2033, reaching a valuation of US$ 12.47 Billion. Anti-inflammatory medications' minor side effects are encouraging an increase in their usage as pain relievers. The effectiveness of pharmaceuticals like diclofenac, ibuprofen, and naproxen as nonsteroidal anti-inflammatory treatments is aiding the sector's growth.


The vast majority of individuals in the region who suffer from chronic spine pain contribute to the market's expansion. Because of rising healthcare costs for the general public and the availability of cutting-edge healthcare systems, the industry for spine pain treatment in North America is gaining momentum. People are becoming more conscious of spine pain, which is expected to increase demand for this treatment in the region.

Get Full Access @  https://www.futuremarketinsights.com/reports/spine-pain-market

The APAC market, on the other hand, is expected to grow at the fastest rate in the coming years, owing to the region's improving healthcare system, rising per-capita income levels, aging population, and burgeoning prevalence of chronic pain. According to a United Nations (UN) Department of Economic and Social Affairs report on global population aging, Asia's elderly population will more than double, from 395 million in 2019 to 587 Million by 2030.

Key Takeaways from the Market Study

  • Nearly 65 million Americans have recently suffered spine pain.
  • Some 16 million adults, or 8% of all adults, suffer from persistent or chronic spine pain, limiting their ability to perform daily tasks.
  • The number of elderly population people in Asia is forecast to double, from 395 million in 2019 to 587 million by 2030.
  • The global Spine Pain market is expected to garner a market value of US$ 47 Billion.
  • The global Spine Pain market is estimated at a market value of US$ 65 Billion.

“As lifestyle changes become apparent, incidences of spinal anomalies and related disorders is becoming more prevalent. Consequently, healthcare practitioners are introducing new approaches to treat spinal problems, providing scope for expansion,” says an FMI analyst.

Market Competition

Key players in the Spine Pain market are Medtronic plc., DePuy Synthes, Inc, Stryker Corporation, NuVasive, Inc, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., Alphatec Spine, Inc, Orthofix International N.V., Difusion Technologies, Inc., ZimVie Inc.

  • In July 2020 - Zavation Medical announced the release of the versatile anterior lumbar plate and Lateral Lumbar Plate, which are intended to be used as supplemental fixation devices for the lumbar spine. These plates are new additions to the company's inventory.
  • In August 2020, WishBone Medical Inc. declared the acquisition of all assets from Back 2 Basics Direct (B2B) and Orbbo Surgical, two confidentially medical device manufacturers specialized in spinal fusion research, advancement, and surgical tools.

Spinal discomfort, also known as back pain, is a common condition that affects many people at some point in their lives. It can range from a dull, constant ache to a sudden, sharp pain, and can occur in the upper back, lower back, or neck.

Key Segments Profiled in the Spine Pain Market Industry Survey

By Product:

  • Fusion Devices
  • Non-Fusion Devices
  • Stimulation Devices

By Treatment:

  • Open Surgery
  • Minimally Invasive Surgery
  • Others

By Procedure:

  • Discectomy
  • Laminotomy
  • Foraminotomy
  • Corpectomy
  • Facetectomy

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more